HLA Monthly Journal Club Topic: Cutting through the weeds. Using adsorption with X-match cells and elution (AXE) technique to sharpen HLA antibody identification and epitope analysis. Presented by: Dr. Robert Liwski CLICK HERE TO REGISTER
Jul 6 8:00 am | Winnipeg, Manitoba, Canada
2022 National Acute Critical Event Simulation (N-ACES) Course
2022 National Acute Critical Event Simulation (N-ACES) Course The Canadian Critical Care Society (CCCS) is extremely excited to welcome first-year critical care subspecialty trainees to our amazing specialty. CCCS is pleased to announce that the annual National Acute Critical Event Simulation (N
Sep 7 7:00 am | Calgary, Alberta, Canada
International Pediatric Nephrology Association Congress
IPNA Congress The Canadian Association of Paediatric Nephrologists (CAPN), representing the 14 centers in Canada, invites you to visit Calgary in September 2022 to attend the 19th Congress of the International Pediatric Nephrology Association (IPNA). The IPNA Congress is held from September 7-11
Lay Science Writing Competition Winner: What does it take to make a life-saving drug?
When you think of proteins, you probably think about chicken, steak, or that new tofu dish your friend made. If I’m lucky, you think about those tiny molecules that your teacher mentioned in biology class. My work is all about those tiny molecules. In my lab at the Centre for Blood Research, I spend my days (and nights) making proteins and testing them to see if they have what it takes to bust up a blood clot and save a life. It’s a long road to get from a test tube to a treatment, and it involves a lot of questions. The first question is: What do we want our drug to do? Heart attacks and
April 21, 2022
Jun 22 11:00 am | Virtual Meeting
CDTRP: Third Annual Patient, Family and Donor Research Forum
The Canadian Donation and Transplantation Research Program in cooperation with the Organ Donation and Transplantation Collaborative and the Canadian Society of Transplantation, is happy to announce the third edition of the Patient, Family and Donor Research Forum dedicated to donation and
Investigating envelope viruses: Tissue factor clotting research earns a first-ranked CIHR Project Grant
How are our normal blood clotting systems affected by viral infections? Could clues to the successful treatment of some of the world’s most challenging viral infections come from understanding how viruses interact with our body’s clot-creating proteins? These are the kinds of questions that Dr. Ed Pryzdial, Canadian Blood Services senior scientist and his laboratory team at the Centre for Blood Research (CBR) in British Columbia have dedicated research efforts to answering; efforts that have recently earned them project funding from the Canadian Institutes of Health Research (CIHR), based on a
April 14, 2022
Apr 6 6:00 am | Virtual session
Promotion: National Campaigns
The Commonwealth Tribute to Life webinar series stems from one of the main pillars of the project: the sharing of knowledge and expertise. The webinars are led by experts from all corners of the Commonwealth and provide a platform for learning and the development of organ donation and
Apr 13 12:00 pm | Live stream
HSOI - 10 Year Anniversary
The High School Outreach Initiative (HSOI) in transplant and organ donation is approaching its 10-year anniversary celebration, taking place in April 2022. We will be celebrating ten successful years of delivering presentations to over 40,000 students since 2012, connecting students in the Greater
What is your role in Innovation and Portfolio Management and what led you to take on this role? I joined Canadian Blood Services in 2021 as the associate director of portfolio management with the goal of developing and leading the product and portfolio management team. This team oversees product lifecycle activities for our collection of fresh blood products (red blood cells, platelets, and plasma), stem cells and diagnostic services. Prior to joining Canadian Blood Services, I spent nearly a decade leading product management activities in the biotechnology industry, overseeing the launch of
March 31, 2022
Introducing pathogen-reduced platelets
In January 2022, Canadian Blood Services introduced pathogen-reduced platelets, a product that is manufactured using pathogen-inactivation technology, at its Ottawa production site. By effectively damaging the nucleic acids of a number of pathogens, pathogen inactivation further reduces the risk of transfusion-transmitted infections—an especially important safeguard against new or emerging pathogens, or pathogens for which tests are not available.
